Literature DB >> 33259856

Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload.

Haifeng Yin1, Amanda J Favreau-Lessard1, Joanne T deKay1, Yodit R Herrmann1, Michael P Robich2, Robert A Koza1, Igor Prudovsky1, Douglas B Sawyer2, Sergey Ryzhov3.   

Abstract

BACKGROUND: Myeloid cells play an important role in a wide variety of cardiovascular disorders, including both ischemic and non-ischemic cardiomyopathies. Neuregulin-1 (NRG-1)/ErbB signaling has recently emerged as an important factor contributing to the control of inflammatory activation of myeloid cells after an ischemic injury. However, the role of ErbB signaling in myeloid cells in non-ischemic cardiomyopathy is not fully understood. This study investigated the role of ErbB3 receptors in the regulation of early adaptive response using a mouse model of transverse aortic constriction (TAC) for non-ischemic cardiomyopathy. METHODS AND
RESULTS: TAC surgery was performed in groups of age- and sex-matched myeloid cell-specific ErbB3-deficient mice (ErbB3MyeKO) and control animals (ErbB3MyeWT). The number of cardiac CD45 immune cells, CD11b myeloid cells, Ly6G neutrophils, and Ly6C monocytes was determined using flow cytometric analysis. Five days after TAC, survival was dramatically reduced in male but not female ErbB3MyeKO mice or control animals. The examination of lung weight to body weight ratio suggested that acute pulmonary edema was present in ErbB3MyeKO male mice after TAC. To determine the cellular and molecular mechanisms involved in the increased mortality in ErbB3MyeKO male mice, cardiac cell populations were examined at day 3 post-TAC using flow cytometry. Myeloid cells accumulated in control but not in ErbB3MyeKO male mouse hearts. This was accompanied by increased proliferation of Sca-1 positive non-immune cells (endothelial cells and fibroblasts) in control but not ErbB3MyeKO male mice. No significant differences in intramyocardial accumulation of myeloid cells or proliferation of Sca-1 cells were found between the groups of ErbB3MyeKO and ErbB3MyeWT female mice. An antibody-based protein array analysis revealed that IGF-1 expression was significantly downregulated only in ErbB3MyeKO mice hearts compared to control animals after TAC.
CONCLUSION: Our data demonstrate the crucial role of myeloid cell-specific ErbB3 signaling in the cardiac accumulation of myeloid cells, which contributes to the activation of cardiac endothelial cells and fibroblasts and development of an early adaptive response to cardiac pressure overload in male mice.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ErbB3; Insulin growth factor-1; Myeloid cells; Non-ischemic cardiomyopathy; Transverse aortic constriction

Mesh:

Substances:

Year:  2020        PMID: 33259856      PMCID: PMC7981250          DOI: 10.1016/j.yjmcc.2020.11.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  100 in total

1.  IGF-1 Overexpression rescues the failing heart.

Authors:  Allen M Samarel
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

2.  Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.

Authors:  Maria Sundvall; Anna Korhonen; Ilkka Paatero; Eugenio Gaudio; Gerry Melino; Carlo M Croce; Rami I Aqeilan; Klaus Elenius
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

3.  CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload.

Authors:  Fanny Laroumanie; Victorine Douin-Echinard; Joffrey Pozzo; Olivier Lairez; Florence Tortosa; Claire Vinel; Christine Delage; Denis Calise; Marianne Dutaur; Angelo Parini; Nathalie Pizzinat
Journal:  Circulation       Date:  2014-03-21       Impact factor: 29.690

4.  Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.

Authors:  Zarha Vermeulen; Anne-Sophie Hervent; Lindsey Dugaucquier; Leni Vandekerckhove; Miche Rombouts; Matthias Beyens; Dorien M Schrijvers; Guido R Y De Meyer; Stuart Maudsley; Gilles W De Keulenaer; Vincent F M Segers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

5.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

Review 6.  Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.

Authors:  Shigeki Higashiyama; Hidehiko Iwabuki; Chie Morimoto; Miki Hieda; Hirofumi Inoue; Natsuki Matsushita
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

7.  Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function.

Authors:  Volker Rudolph; Tanja K Rudolph; J Christopher Hennings; Stefan Blankenberg; Renate Schnabel; Daniel Steven; Munif Haddad; Katharina Knittel; Silke Wende; Jürgen Wenzel; Thomas Münzel; Thomas Heitzer; Thomas Meinertz; Christian Hübner; Stephan Baldus
Journal:  Free Radic Biol Med       Date:  2007-07-19       Impact factor: 7.376

Review 8.  Endocytosis and intracellular trafficking of ErbBs.

Authors:  Alexander Sorkin; Lai Kuan Goh
Journal:  Exp Cell Res       Date:  2008-08-28       Impact factor: 3.905

9.  Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation.

Authors:  Jingjing Tang; Jeremy M Frey; Carole L Wilson; Angela Moncada-Pazos; Clémence Levet; Matthew Freeman; Michael E Rosenfeld; E Richard Stanley; Elaine W Raines; Karin E Bornfeldt
Journal:  Mol Cell Biol       Date:  2018-08-15       Impact factor: 4.272

Review 10.  Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.

Authors:  Sang-Bing Ong; Sauri Hernández-Reséndiz; Gustavo E Crespo-Avilan; Regina T Mukhametshina; Xiu-Yi Kwek; Hector A Cabrera-Fuentes; Derek J Hausenloy
Journal:  Pharmacol Ther       Date:  2018-01-09       Impact factor: 12.310

View more
  2 in total

Review 1.  A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.

Authors:  Mohammed I El-Gamal; Nada H Mewafi; Nada E Abdelmotteleb; Minnatullah A Emara; Hamadeh Tarazi; Rawan M Sbenati; Moustafa M Madkour; Seyed-Omar Zaraei; Afnan I Shahin; Hanan S Anbar
Journal:  Molecules       Date:  2021-12-05       Impact factor: 4.411

Review 2.  Neuregulin-1, a potential therapeutic target for cardiac repair.

Authors:  Yan Wang; Jianliang Wei; Peng Zhang; Xin Zhang; Yifei Wang; Wenjing Chen; Yanan Zhao; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.